Valery M Gordon

Title: Valery M Gordon: Innovator in Immunogenic Toxin Research

Introduction

Valery M Gordon is a notable inventor based in Kensington, MD (US). She has made significant contributions to the field of immunogenic research, particularly in the development of vaccines targeting specific toxins. Her work has implications for both human and animal health, showcasing her dedication to advancing scientific knowledge.

Latest Patents

Valery M Gordon holds a patent for "Immunogenic Shiga-Like Toxin II Variant Mutants." This patent discloses immunogenic mutant Shiga-Like Toxin II variants and vaccines containing such toxins. The mutant toxin comprises an SLT-IIv where the amino acid at position 167 in the A subunit has been replaced by a differently charged amino acid that essentially maintains the structure of the native A subunit. In a preferred embodiment, the glutamic acid is replaced with glutamine. An analogous modification may also be made at position 170. The vaccines developed from this research are used for the treatment of edema disease in swine.

Career Highlights

Throughout her career, Valery M Gordon has worked with various organizations, including Microcarb, Inc. and the U.S. Government as represented by the Secretary of the Army. Her experience in these institutions has allowed her to apply her innovative ideas in practical settings, contributing to advancements in immunogenic research.

Collaborations

Valery has collaborated with notable professionals in her field, including her coworker James E Samuel. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Valery M Gordon's contributions to immunogenic toxin research and her innovative patents highlight her role as a significant figure in the scientific community. Her work continues to influence vaccine development and animal health, demonstrating the importance of her research in addressing critical health challenges.